Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Micronize diosmin and hesperidine composition suppository

A technology of diosmin and hesperidin, which is applied in the field of medicine, can solve the problems that the blood drug concentration cannot be maintained within the therapeutic range, cannot be taken on time, and low bioavailability, so as to avoid the first-pass effect and reduce the number of medications , reduce toxicity and side effects

Inactive Publication Date: 2006-08-30
刘展欣
View PDF1 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] Currently, diosmin and hesperidin mixture tablets are on the market, which are clinically used as hemorrhoid medicine, antiphlebitis and antivaricose veins, but it has a first-pass effect, which leads to a large loss of flavonoids and low bioavailability. Lead to taking large doses and taking more frequently
It is inconvenient for patients who are busy with work to take medication, and often cannot take it on time, resulting in blood drug concentration that cannot be maintained within the therapeutic range
And the dosage of taking is big, causes the raising of cost, also brings certain economic burden to patient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Micronize diosmin and hesperidine composition suppository
  • Micronize diosmin and hesperidine composition suppository

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Example 1 A micronized diosmin and hesperidin suppository

[0043] Diosmin 45g

[0044] and Hesperidin 5g

[0045] PEG 4000 80g

[0046] PEG 6000 60g

[0047] Under high airflow, micronize diosmin and hesperidin to obtain powder particles with an average particle size of about 5 μm, heat and melt PEG4000 and PEG6000, mix well, and add the micronized mixture of diosmin and hesperidin , add and stir, pour into a suppository mold coated with lubricant, condense, and make 100 suppositories.

Embodiment 2

[0048] Example 2 A micronized diosmin and hesperidin suppository

[0049] Diosmin 42g

[0050] Hesperidin 8g

[0051] Sodium Benzoate 10mg

[0052] Semi-synthetic fatty acid glycerides 150g

[0053] Under high air flow, diosmin and hesperidin were micronized to obtain powder particles with an average particle size of about 2.5 μm, and the micronized diosmin and hesperidin were mixed evenly with sodium benzoate to obtain a mixed powder. Semi-synthetic fatty acid glycerides are melted on a water bath, and the mixed powder is added to the melted matrix, and stirred evenly to form a uniform suspension. Pour it into the suppository mold, scrape off the excess material after cooling, and demould, and then make 100 suppositories.

[0054] The effect of the micronized diosmin and hesperidin composition suppository of the present invention is illustrated by experiments below:

[0055] The pharmacokinetic characteristics and comparison of the micronized diosmin and hesperidin compo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A composite suppository for treating pile, phlebitis and phlebeurysma is prepared from micro-granular diosmin and hesperidin, matrix for suppository and additive.

Description

field of invention [0001] The invention relates to the technical field of medicine, in particular the invention relates to a micronized diosmin and hesperidin composition suppository, which is clinically used as hemorrhoid medicine, antiphlebitis and antivaricose veins. Background of the invention [0002] Hemorrhoids, phlebitis, and varicose veins are all common frequently-occurring diseases, which are caused by various complex factors such as abnormal hemorheology and poor microcirculation. At present, the treatment methods for this disease are divided into surgical treatment and drug treatment. Although surgical treatment is relatively thorough, it is painful for patients, and it is difficult to avoid recurrence elsewhere, and it may also leave certain sequelae such as anal stenosis. Therefore, patients generally adopt drug treatment, and the commonly used ones are external medicines such as Huazhi suppository, hemorrhoid ointment, etc., and their effects are detumescence...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K9/02A61P9/14
Inventor 刘展欣
Owner 刘展欣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com